![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/4745 | |
A61K 31/496 | |||
A61K 31/513 | |||
A61K 31/7072 | |||
A61K 39/395 | |||
A61K 9/127 | |||
A61P 35/00 |
(11) | Number of the document | 2344161 |
(13) | Kind of document | T |
(96) | European patent application number | 09820164.3 |
Date of filing the European patent application | 2009-10-16 | |
(97) | Date of publication of the European application | 2011-07-20 |
(45) | Date of publication and mention of the grant of the patent | 2018-12-19 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/CA2009/001483 |
Date | 2009-10-16 |
(87) | Number | WO 2010/043050 |
Date | 2010-04-22 |
(30) | Number | Date | Country code |
106109 P | 2008-10-16 | US |
(72) |
TARDI, Paul, CA
MAYER, Lawrence, CA
BERMUDES, David, US
|
(73) |
Celator Pharmaceuticals, Inc.,
200 Princeton South Corporate Center, Suite 180, Ewing, NJ 08628,
US
|
(54) | COMBINATIONS OF A LIPOSOMAL WATER-SOLUBLE CAMPTOTHECIN WITH CETUXIMAB OR BEVACIZUMAB |
COMBINATIONS OF A LIPOSOMAL WATER-SOLUBLE CAMPTOTHECIN WITH CETUXIMAB OR BEVACIZUMAB |